Home The Word Brain	My Amedeo FAQ Privacy About
	Amedeo Chinese For Medical Students & Physicians A complete 20-lesson, 300-page Chinese course with a companion app in 21 languages — free forever. Download the free PDF: Amedeo Chinese PDF

Irritable Bowel Syndrome

Free Subscription Articles published in J Gastroenterol Hepatol Retrieve available abstracts of 53 articles: HTML format

Single Articles

August 2026
1. CHENGJIAO Y, Zerui Z, Mengjun P, Liming L, et al
   Differences in the Plasma Bile Acid-Gut Microbiota Axis Between IBS-D and IBS-C.
   J Gastroenterol Hepatol. 2026 Aug 18. doi: 10.1111/jgh.70669.
   PubMed     Abstract available
   
   
   
2. ZHONG J, Xu Z, Chen W, Jiang Y, et al
   Consolidation Therapy of Probiotics With Rifaximin Prevent Relapse in Rifaximin-Responsive Diarrhea-Predominant Irritable Bowel Syndrome: A Multicenter Randomized Clinical Trial.
   J Gastroenterol Hepatol. 2026 Aug 18. doi: 10.1111/jgh.70672.
   PubMed     Abstract available
   
   
   July 2026
3. NEO KML, How AL, Ang AYH, Pang GY, et al
   Cost-of-Illness of Irritable Bowel Syndrome: A Systematic Review.
   J Gastroenterol Hepatol. 2026 Jul 31. doi: 10.1111/jgh.70618.
   PubMed     Abstract available
   
   
   June 2026
4. LI S, Lin K, Che K
   Comments on "Reassessing Small Intestinal Bacterial Overgrowth in Irritable Bowel Syndrome: A Comparative Study of Diagnostic Guidelines and Their Clinical Relevance".
   J Gastroenterol Hepatol. 2026 Jun 24. doi: 10.1111/jgh.70530.
   PubMed    
   
   
   
5. AROOBA FNU, Hidayat A, Umar M
   "Reassessing Small Intestinal Bacterial Overgrowth in Irritable Bowel Syndrome: A Comparative Study of Diagnostic Guidelines and Their Clinical Relevance" by Loh et al.
   J Gastroenterol Hepatol. 2026 Jun 21. doi: 10.1111/jgh.70528.
   PubMed    
   
   
   
6. XU L
   Letter to the Editor: Reassessing Small Intestinal Bacterial Overgrowth in Irritable Bowel Syndrome: A Comparative Study of Diagnostic Guidelines and Their Clinical Relevance.
   J Gastroenterol Hepatol. 2026 Jun 21. doi: 10.1111/jgh.70531.
   PubMed    
   
   
   
7. ZHUANG H
   Letter to the Editor: Reassessing Small Intestinal Bacterial Overgrowth in Irritable Bowel Syndrome: A Comparative Study of Diagnostic Guidelines and Their Clinical Relevance.
   J Gastroenterol Hepatol. 2026 Jun 19. doi: 10.1111/jgh.70516.
   PubMed    
   
   
   
8. ZHU J, Qiu X, Ma R
   Comment on "Efficacy and Safety of Postbiotics in Irritable Bowel Syndrome: A Systematic Review and Meta-Analysis".
   J Gastroenterol Hepatol. 2026 Jun 7. doi: 10.1111/jgh.70482.
   PubMed    
   
   
   
9. LOH AJC, Loo QY, Ng AK, Khoo XH, et al
   Reassessing Small Intestinal Bacterial Overgrowth in Irritable Bowel Syndrome: A Comparative Study of Diagnostic Guidelines and Their Clinical Relevance.
   J Gastroenterol Hepatol. 2026 Jun 3. doi: 10.1111/jgh.70477.
   PubMed     Abstract available
   
   
   May 2026
10. HE Y
    Re-Evaluating Probiotic Efficacy in Irritable Bowel Syndrome: A Call for Rigorous Statistics, Digital Therapeutics, and Microbiome-Driven Precision.
    J Gastroenterol Hepatol. 2026 May 29. doi: 10.1111/jgh.70459.
    PubMed    
    
    
    
11. SUN K, Peng J, Zhu Y
    Probiotic Blend of Lactobacillus acidophilus LA-5 and Bifidobacterium animalis ssp. Lactis BB-12 in Non-Constipated Irritable Bowel Syndrome: A Double-Blind Randomized Placebo-Controlled Trial.
    J Gastroenterol Hepatol. 2026 May 15. doi: 10.1111/jgh.70454.
    PubMed    
    
    
    
12. REN Z, Zhu H
    Comment on "Probiotics for Irritable Bowel Syndrome: An Updated Systematic Review and Meta-Analysis With Trial Sequential Analysis".
    J Gastroenterol Hepatol. 2026 May 14. doi: 10.1111/jgh.70443.
    PubMed    
    
    
    
13. AYAD ME, Yu S, El Shennawy S, Al Mowafy EA, et al
    Efficacy and Safety of Postbiotics in Irritable Bowel Syndrome: A Systematic Review and Meta-Analysis.
    J Gastroenterol Hepatol. 2026 May 8. doi: 10.1111/jgh.70421.
    PubMed     Abstract available
    
    
    March 2026
14. TAO X
    Comment on "Associations of Long-Term Night Shift Work With Incident Irritable Bowel Syndrome: A Population-Based Cohort Study".
    J Gastroenterol Hepatol. 2026 Mar 21. doi: 10.1111/jgh.70363.
    PubMed    
    
    
    
15. TANG ASP, Quek J, Sulaimi F, Sim B, et al
    Probiotics for Irritable Bowel Syndrome: An Updated Systematic Review and Meta-Analysis With Trial Sequential Analysis.
    J Gastroenterol Hepatol. 2026 Mar 12. doi: 10.1111/jgh.70322.
    PubMed     Abstract available
    
    
    February 2026
16. LI X
    Reconsidering Bloating as a Core Endpoint in IBS-C: Commentary on Brenner et al. (2025).
    J Gastroenterol Hepatol. 2026 Feb 26. doi: 10.1111/jgh.70320.
    PubMed    
    
    
    January 2026
17. MACK A, Halmos EP, Mogilevski T, Anderson EJ, et al
    A Critical Review of Persistent Gastrointestinal and Extraintestinal Symptoms in Quiescent Inflammatory Bowel Disease: Time for Greater Precision and Clarity.
    J Gastroenterol Hepatol. 2026 Jan 18. doi: 10.1111/jgh.70223.
    PubMed     Abstract available
    
    
    December 2025
18. SIMADIBRATA DM, Koo TH, Utari AP, Ayad M, et al
    Rome III Versus Rome IV Criteria for Diagnosing Irritable Bowel Syndrome in a Southeast Asian Population: Insights From the Rome Foundation Global Epidemiology Study Household Survey.
    J Gastroenterol Hepatol. 2025 Dec 4. doi: 10.1111/jgh.70174.
    PubMed     Abstract available
    
    
    November 2025
19. GHOSHAL UC, Ramakrishna BS, Rathi PM, Shukla A, et al
    Probiotic Blend of Lactobacillus acidophilus LA-5 and Bifidobacterium animalis ssp. Lactis BB-12 in Non-constipated Irritable Bowel Syndrome: A Double-Blind Randomized Placebo-Controlled Trial.
    J Gastroenterol Hepatol. 2025 Nov 18. doi: 10.1111/jgh.70137.
    PubMed     Abstract available
    
    
    
20. BRENNER DM, Shin AS, Laitman AP, Deutsch JK, et al
    The Effectiveness of Plecanatide for Treating Constipation and Bloating in Patients Aged 18 to 40 Years With Irritable Bowel Syndrome: Utilization of a New Composite Trisymptom Endpoint.
    J Gastroenterol Hepatol. 2025 Nov 10. doi: 10.1111/jgh.70119.
    PubMed     Abstract available
    
    
    
21. YAO YH, Li SN, Yin Q, Liu L, et al
    Comment on "Associations of Long-Term Night Shift Work With Incident Irritable Bowel Syndrome: A Population-Based Cohort Study".
    J Gastroenterol Hepatol. 2025 Nov 3. doi: 10.1111/jgh.70140.
    PubMed    
    
    
    October 2025
22. DU Y, Fan H
    Comment on "Associations of Long-Term Night Shift Work With Incident Irritable Bowel Syndrome: A Population-Based Cohort Study".
    J Gastroenterol Hepatol. 2025 Oct 7. doi: 10.1111/jgh.70113.
    PubMed    
    
    
    
23. KARKRA R
    The Association Between Night Shifts and Irritable Bowel Syndrome.
    J Gastroenterol Hepatol. 2025 Oct 1. doi: 10.1111/jgh.70101.
    PubMed    
    
    
    September 2025
24. AHMED A, Chauhan A, Kumari A, Hokari R, et al
    Prevalence of Serologically Defined Celiac Disease in Patients With Irritable Bowel Syndrome in Asia: A Multicountry Hospital-Based Study.
    J Gastroenterol Hepatol. 2025 Sep 13. doi: 10.1111/jgh.70074.
    PubMed     Abstract available
    
    
    July 2025
25. YAN Y, Liu L, Shen XJ
    Comment on "Impact of Positive Glucose, Lactose, and Fructose Hydrogen Breath Tests on Symptoms and Quality of Life in Irritable Bowel Syndrome".
    J Gastroenterol Hepatol. 2025 Jul 23. doi: 10.1111/jgh.70032.
    PubMed    
    
    
    
26. YAO Y, You X, Yang S, Xie Y, et al
    Associations of Long-Term Night Shift Work With Incident Irritable Bowel Syndrome: A Population-Based Cohort Study.
    J Gastroenterol Hepatol. 2025 Jul 12. doi: 10.1111/jgh.70002.
    PubMed     Abstract available
    
    
    March 2025
27. CHENG L, Wang Q, Wu B, Yan X, et al
    Efficacy of Linaclotide in Functional Dyspepsia and Constipation-Predominant Irritable Bowel Syndrome Overlap: A Randomized Trial.
    J Gastroenterol Hepatol. 2025 Mar 13. doi: 10.1111/jgh.16925.
    PubMed     Abstract available
    
    
    January 2025
28. LOO QY, Chuah KH, Hian WX, Khoo XH, et al
    Impact of Positive Glucose, Lactose, and Fructose Hydrogen Breath Tests on Symptoms and Quality of Life in Irritable Bowel Syndrome.
    J Gastroenterol Hepatol. 2025 Jan 23. doi: 10.1111/jgh.16891.
    PubMed     Abstract available
    
    
    
29. YU QX, Wang DD, Dong PJ, Zheng LH, et al
    Probiotics Combined With Trimebutine for the Treatment of Irritable Bowel Syndrome Patients: A Systematic Review and Meta-Analysis.
    J Gastroenterol Hepatol. 2025 Jan 8. doi: 10.1111/jgh.16858.
    PubMed     Abstract available
    
    
    December 2024
30. HISAKI Y, Sawada A, Kobayashi Y, Nishida Y, et al
    Epidemiology of Rome IV Fecal Incontinence in Japan: An Internet Survey of 9995 Individuals.
    J Gastroenterol Hepatol. 2024 Dec 2. doi: 10.1111/jgh.16838.
    PubMed     Abstract available
    
    
    November 2024
31. AGGARWAL N, Bhatia U, Dwarakanathan V, Singh AD, et al
    Prevalence and etiologies of non-responsive celiac disease: A systematic review and meta-analysis.
    J Gastroenterol Hepatol. 2024 Nov 18. doi: 10.1111/jgh.16808.
    PubMed     Abstract available
    
    
    August 2024
32. GONG Q, Xiong F, Zheng Y, Guo Y, et al
    Tea-derived exosome-like nanoparticles prevent irritable bowel syndrome induced by water avoidance stress in rat model.
    J Gastroenterol Hepatol. 2024 Aug 9. doi: 10.1111/jgh.16714.
    PubMed     Abstract available
    
    
    July 2024
33. WANG J, Sui WN, Zhao YQ, Meng SY, et al
    Genetic evidence for the causal impact of insomnia on gastrointestinal diseases and the mediating effects of adiposity traits.
    J Gastroenterol Hepatol. 2024 Jul 9. doi: 10.1111/jgh.16678.
    PubMed     Abstract available
    
    
    May 2024
34. NG QX, Yaow CYL, Moo JR, Koo SWK, et al
    A systematic review of the association between environmental risk factors and the development of irritable bowel syndrome.
    J Gastroenterol Hepatol. 2024 May 3. doi: 10.1111/jgh.16587.
    PubMed     Abstract available
    
    
    January 2024
35. CHUAH KH, Mahadeva S
    Can we predict who will respond to a low-FODMAP diet in irritable bowel syndrome?
    J Gastroenterol Hepatol. 2024 Jan 18. doi: 10.1111/jgh.16487.
    PubMed    
    
    
    November 2023
36. GHOSHAL UC, Mustafa U, Mukhopadhyay SK
    FODMAP meal challenge test: a novel investigation to predict response to low-FODMAP diet in non-constipating irritable bowel syndrome.
    J Gastroenterol Hepatol. 2023 Nov 28. doi: 10.1111/jgh.16424.
    PubMed     Abstract available
    
    
    
37. KWAK N, Lee H, Kim BK, Yu YM, et al
    Association between selective serotonin reuptake inhibitor use and developing irritable bowel syndrome through retrospective analysis.
    J Gastroenterol Hepatol. 2023 Nov 13. doi: 10.1111/jgh.16406.
    PubMed     Abstract available
    
    
    September 2023
38. ZLOOF Y, Peretz L, Braun M, Simchoni M, et al
    Hypermobility spectrum disorders and irritable bowel syndrome: A nationwide study of 1.6 million adolescents.
    J Gastroenterol Hepatol. 2023 Sep 2. doi: 10.1111/jgh.16341.
    PubMed     Abstract available
    
    
    June 2023
39. FUTAGAMI S, Kessoku T, Kasai Y, Higurashi T, et al
    Comparison of pancreatic enzyme abnormalities and protease-activated receptor-2-positive eosinophils in the duodenum of patients with functional dyspepsia-irritable bowel syndrome overlap with functional dyspepsia alone in Asian populations.
    J Gastroenterol Hepatol. 2023 Jun 6. doi: 10.1111/jgh.16250.
    PubMed     Abstract available
    
    
    March 2023
40. OKUYAMA Y, Matsui D, Ozaki E, Watanabe Y, et al
    Association of low occlusal force as an oral hypofunction with the prevalence of irritable bowel syndrome in Japanese adults.
    J Gastroenterol Hepatol. 2023 Mar 12. doi: 10.1111/jgh.16175.
    PubMed     Abstract available
    
    
    
41. KHOO XH, Chong CW, Talha AM, Philip K, et al
    The impact of diet and ethnicity on Gut Microbiota Variation in Irritable Bowel Syndrome: A Multi-centre Study.
    J Gastroenterol Hepatol. 2023 Mar 12. doi: 10.1111/jgh.16174.
    PubMed     Abstract available
    
    
    
42. YASUDA R, Arai K, Kudo T, Nambu R, et al
    Serum leucine-rich alpha-2 glycoprotein and calprotectin in children with inflammatory bowel disease: a multicenter study in Japan.
    J Gastroenterol Hepatol. 2023 Mar 6. doi: 10.1111/jgh.16166.
    PubMed     Abstract available
    
    
    
43. DENG X, Xiao L, Luo M, Xie P, et al
    Intestinal Crosstalk between Bile Acids and Microbiota in irritable bowel syndrome.
    J Gastroenterol Hepatol. 2023 Mar 3. doi: 10.1111/jgh.16159.
    PubMed     Abstract available
    
    
    December 2022
44. YANPING W, Gao X, Cheng Y, Liu M, et al
    The Interaction between Obesity and Visceral Hypersensitivity.
    J Gastroenterol Hepatol. 2022 Dec 7. doi: 10.1111/jgh.16083.
    PubMed     Abstract available
    
    
    November 2022
45. GWEE KA, Lee YY, Suzuki H, Ghoshal UC, et al
    Asia-Pacific Guidelines for Managing Functional Dyspepsia Overlapping with Other Gastrointestinal Symptoms.
    J Gastroenterol Hepatol. 2022 Nov 1. doi: 10.1111/jgh.16046.
    PubMed     Abstract available
    
    
    August 2022
46. LI X, Ren K, Hong X, Guo S, et al
    Ameliorating Effects of Electroacupuncture on the Low-grade Intestinal Inflammation in Rat Model of Diarrhea-predominant Irritable Bowel Syndrome.
    J Gastroenterol Hepatol. 2022 Aug 12. doi: 10.1111/jgh.15981.
    PubMed     Abstract available
    
    
    June 2022
47. ZHANG Y, Fu F, Zhang L, Zhang W, et al
    Telomere is Shortened in Patients with Irritable Bowel Syndrome in the Chinese Population.
    J Gastroenterol Hepatol. 2022 Jun 15. doi: 10.1111/jgh.15912.
    PubMed     Abstract available
    
    
    May 2022
48. BEK S, Teo YN, Tan XH, Fan KH, et al
    Association between Irritable Bowel Syndrome and Micronutrients: A Systematic Review.
    J Gastroenterol Hepatol. 2022 May 17. doi: 10.1111/jgh.15891.
    PubMed     Abstract available
    
    
    
49. ABUELAZM M, Abdelazeem B
    Vitamin D Supplementation for Irritable Bowel Syndrome: Concerns About the Meta-Analysis.
    J Gastroenterol Hepatol. 2022 May 5. doi: 10.1111/jgh.15883.
    PubMed    
    
    
    
50. UNO Y
    Paradigm shift in FODMAP theory.
    J Gastroenterol Hepatol. 2022;37:954.
    PubMed    
    
    
    April 2022
51. CHONG RIH, Yaow CYL, Loh CYL, Teoh SE, et al
    Vitamin D Supplementation for Irritable Bowel Syndrome: A Systematic Review and Meta-Analysis.
    J Gastroenterol Hepatol. 2022 Apr 8. doi: 10.1111/jgh.15852.
    PubMed     Abstract available
    
    
    
52. FAN K, Eslick GD, Nair PM, Burns GL, et al
    HUMAN INTESTINAL SPIROCHETOSIS, IRRITABLE BOWEL SYNDROME AND COLONIC POLYPS: A SYSTEMATIC REVIEW AND META-ANALYSIS.
    J Gastroenterol Hepatol. 2022 Apr 6. doi: 10.1111/jgh.15851.
    PubMed     Abstract available
    
    
    March 2022
53. ROTH B, Larsson E, Ohlsson B
    Poor intake of vitamins and minerals among patients with irritable bowel syndrome is associated with symptoms.
    J Gastroenterol Hepatol. 2022 Mar 18. doi: 10.1111/jgh.15830.
    PubMed     Abstract available
    
    

Thank you for your interest in scientific medicine.

AMEDEO Irritable Bowel Syndrome is free of charge. Privacy / Datenschutzerklärung | Imprint / Impressum